Genesis HealthCare Sets New Course to Strengthen Future
KENNETT SQUARE, Pa., July 10, 2025--(BUSINESS WIRE)--Genesis HealthCare, Inc., along with its subsidiaries, announced today that it has taken steps to implement a financial restructuring to secure the long-term delivery of its mission. This process is designed to ensure that the Company can continue operating in a seamless manner, while also allowing the Company to address its legacy liabilities associated with previously divested operations.
To facilitate the Company's restructuring efficiently and with minimal disruption to ongoing operations, the Company has filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Northern District of Texas Dallas Division (the "Court").
"We have much to be proud of for the tremendous progress we have made as an organization over the last several years as we have implemented a forward-looking, enterprise-wide shift from centralized to market-based operations," said David Harrington, Executive Chairman of the Genesis HealthCare, Inc., Board of Directors. "Our ongoing work has confirmed that, to maintain our momentum, we must address our legacy debt structure. The goal of this filing is to emerge a stronger, healthier company poised to exceed our goals for clinical and operational excellence."
Chapter 11 of the U.S. Bankruptcy Code guides how a company can restructure its debt while continuing to operate normally during the reorganization. Subject to Court approval, the Company has secured a commitment of $30 million in debtor-in-possession (DIP) financing, from its existing secured lenders. This DIP financing, combined with cash on hand and cash flow generated from ongoing operations, will support the business to satisfy its ongoing obligations, and enable the Company to remain focused on delivering quality care during the Court-supervised process.
Importantly, the filing includes provisions to ensure that staff will retain their positions, pay and benefits so that patients and residents will continue to be served by the providers they trust. Vendor agreements will remain in place while the process moves forward.
"We believe this financial reorganization is a necessary step for our organization to sustainably deliver on our mission of improving lives through delivery of high-quality healthcare and everyday compassion," said Lauren Murray, Genesis HealthCare Chief Operating Officer. "We assure all those who rely on us for care that we remain fully focused on and committed to providing the high-quality care you have come to expect, and we thank you for your continued confidence. This process is designed to ensure that we can continue to deliver on that commitment. We also are grateful for our talented staff and their dedication to excellence, which has positioned Genesis HealthCare for continued growth and a bright future."
Court filings and additional information related to the proceedings, which include a proposed transaction involving a current affiliate, are available at https://dm.epiq11.com/Genesis. The proposed transaction is subject to higher bidding and court approval, and would result in the current affiliate acquiring the Company's operations. Those with further questions can call (toll-free in the US) 888-861-3979.
Advisors
McDermott Will & Emery LLP is serving as legal counsel, Ankura Consulting is providing financial restructuring and Chief Restructuring Officer services (Russell A. Perry and Louis E. Robichaux IV, Co-CROs), and Jefferies is serving as exclusive investment banker.
ABOUT GENESIS HEALTHCARE, INC.
Genesis HealthCare, Inc. is a holding company with affiliates that operate skilled nursing facilities and assisted/senior living communities. Its subsidiaries also specialize in contract rehabilitation therapy, respiratory therapy, physician services, and accountable care, collectively referred to as Genesis HealthCare. To learn more, visit www.genesishcc.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250709421045/en/
Contacts
MEDIA CONTACT mediainquiry@genesishcc.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
BofA Maintains a Buy Rating on PG&E Corporation (PCG), Sets a $24 PT
PG&E Corporation (NYSE:PCG) is one of the best cheap stocks with huge upside potential. On June 11, Bank of America Securities analyst Ross Fowler maintained a Buy rating on PG&E Corporation (NYSE:PCG) and set a price target of $24.00. Brightly-lit nighttime view of an electricity power grid with distribution lines and transmission substations. The company's fiscal Q1 2025 earnings showed GAAP earnings of $0.28 per share, compared to earnings of $0.34 per share in fiscal Q1 2024. Non-GAAP core earnings for the quarter were $0.33 per share compared to $0.37 per share for the same period last year. PG&E Corporation (NYSE:PCG) also constructed 26 miles of strengthened poles and covered power lines and 24 miles of underground power lines in areas with high wildfire risks. Between 2025 and 2026, the Utility has plans for the construction of around 500 miles of other wildfire safety system upgrades and 700 miles of underground power lines. PG&E Corporation (NYSE:PCG) generates, transmits, and distributes natural gas and electricity to customers. The company specializes in utility, electricity, energy, power, solar, gas, and sustainability. While we acknowledge the potential of PCG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
23 minutes ago
- Yahoo
Navios Maritime Partners (NMM) Announces $35.5 Million Sale of a 2009-Built Containership
Navios Maritime Partners L.P. (NYSE:NMM) is one of the best cheap stocks with huge upside potential. Navios Maritime Partners L.P. (NYSE:NMM) undertook the delivery of Nave Dorado, a newly built Aframax/LR2 tanker vessel, in April, boosting its operational capacity. A large container ship floating in a harbor, its cargo illuminated by the setting sun. In addition, the company announced in May an agreement to sell a 2009-built containership for $35.5 million. The transaction for this deal is expected to be completed in the second half of 2025. These strategic moves mark the company's ongoing efforts for fleet optimization and financial performance improvement, potentially affecting stakeholder interests and its market positioning. Navios Maritime Partners L.P. (NYSE:NMM) reported $304.1 million in revenue in fiscal Q1 2025, while net income for the quarter reached $41.7 million. Navios Maritime Partners L.P. (NYSE:NMM) is a shipping and logistics company that owns and manages dry cargo and container vessels. The company's focus is on the transport and transhipment of dry bulk commodities, which include coal, iron ore, and grain. While we acknowledge the potential of NMM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
23 minutes ago
- Yahoo
Barclays Loweres PT on Aon plc Stock to $401, Maintains Overweight Rating
Aon plc (NYSE:AON) is one of the . On July 7, Barclays lowered the price target of Aon plc (NYSE:AON) from $415 to $401, maintaining its Overweight rating on the stock. Barclays analyst Alex Scott has kept his rating while reducing the price target on AON ahead of the Q2 2025 earnings. The analyst believes that Aon plc remains more cautious on property and casualty carriers, pointing out that the underwriting margins face pressure from unfavourable mix shifts and softening rates. A close-up of a financial analyst in a modern office while reviewing long-term investment opportunities. Scott is more constructive on reinsurers due to 'idiosyncratic tailwinds' and capital return potential in the second half of 2025. During Q1, the company saw 4% organic revenue growth in the reinsurance segment. The company expects to achieve its 2025 full-year guidance, expecting mid-single-digit or greater organic revenue growth and double-digit FCF growth. Aon plc (NYSE:AON) is a global professional services firm that operates through two segments, including Risk Capital and Human Capital. While we acknowledge the potential of AON as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
